Shandong University of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Jinan China (1958)

Organization Overview

First Clinical Trial
2010
NCT01356511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Shandong Univercity of TCM | Department of Cardiology, Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine | Shandong University of Traditional Chinese Medicine | The Affiliated Hospital of Shandong University of Chinese Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Aplastic (Phase 4)

Angina Pectoris (Phase 2)

Angina, Stable (Phase 2)

Blind Loop Syndrome (Phase 2)

Cerebral Infarction (Phase 4)

Communicable Diseases (Phase 4)

Coronary Artery Disease (Phase 2)

Fibrosis (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Infections (Phase 4)

Ischemia (Phase 4)

Liver Cirrhosis (Phase 4)

Peripheral Nervous System Diseases (Phase 2)

Purpura (Phase 4)

Purpura, Thrombocytopenic (Phase 4)

Purpura, Thrombocytopenic, Idiopathic (Phase 4)

Respiratory Tract Infections (Phase 4)

Stroke (Phase 4)

Thrombocytopenia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 26